Comparison between fenoterol and fenoterol plus oxitropium bromide delivered by metered-dose inhaler with InspirEase to relieve acute asthma attack

Journal of Asthma

Volumn 36, Issue 1, 1999, Pages 67-75

  Kamei, Tadashi ^a   Fujita, Jiro ^b   Okada, Hiroki ^b   Nakamura, Hiroyuki ^c   Kishimoto, Takumi ^d   Momoi, Atsuko ^e   Kawaji, Koji ^f   Yoshinouchi, Takeo ^g   Ueda, Nobuo ^h   Takahara, Jiro ^b  

^a KAGAWA PREFECTURAL CENTRAL HOSPITAL   (Japan)

^b KAGAWA UNIVERSITY   (Japan)

^c Asada General Hospital   (Japan)

^d OKAYAMA ROSAI HOSPITAL   (Japan)

^e Sakaide City Hospital   (Japan)

^f TAKAMATSU RED CROSS HOSPITAL   (Japan)

^g Matsuyama Rehabilitation Hospital   (Japan)

^h EHIME PREFECTURAL CENTRAL HOSPITAL   (Japan)

Author keywords

Acute asthma attack; Fenoterol inhalation; Metered dose inhaler; Oxitropium inhalation

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; FENOTEROL; OXITROPIUM BROMIDE;

ADULT; ARTICLE; ASTHMA; ASTHMATIC STATE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; INHALATIONAL DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; METERED DOSE INHALER; MULTICENTER STUDY; PEAK EXPIRATORY FLOW; RANDOMIZED CONTROLLED TRIAL;

EID: 13044253478     PISSN: 02770903     EISSN: None     Source Type: Journal    
DOI: 10.3109/02770909909065151     Document Type: Article

References (16)

1. FitzGerald JM, Hargreave FE: The assessment and management of acute life threatening asthma. Chest 95:888-894 (1989).
2. Morley TF, Marozsan E, Zappasodi SJ, Gordon R, Griesback R, Giudice JC: Comparison of beta-adrenergic agents delivered by nebulizer vs metered dose inhaler with InspirEase in hospitalized asthmatic patients. Chest 94:1205-1210 (1988).
3. Colacone A, Afilalo M, Wolkove N, Kreisman H: A comparison of albuterol administered by metered dose inhaler (and holding chamber) or wet nebulizer in acute asthma. Chest 104:835-841 (1993).
4. FitzGerald JM, Grunfeld A, Pare PD, Levy RD, Newhouse MT, Hodder R, Chapman KR, the Canadian Combivent Study Group: The clinical efficacy of combination nebulized anticholinergic and adrenergic bronchodilators vs nebulized adrenergic bronchodilator alone in acute asthma. Chest 111:311-315 (1997).
5. Louw SJ, Goldin JG, Varis S: Relative efficacy of nebulized ipratropium bromide and fenoterol in acute severe asthma. S Afr Med J 77:24-26 (1990).
6. O'Driscoll BR, Taylor RJ, Horsley MG, et al: Nebulized salbutamol with and without ipratropium bromide in acute airflow obstruction. Lancet 11:1418-1420 (1989).
7. Higgins RM, Stradling JR, Lane DJ: Should ipratropium bromide be added to beta agonists in the treatment of acute severe asthma? Chest 94:718-722 (1988).
8. Rebuck AS, Chapman KR, Abboud R, et al: Nebulized anticholinergic and sympathomimetic treatment of asthma and chronic obstructive airways disease in the emergency room. Am J Med 82:59-64 (1987).
9. Ward MJ, MacFarlane JT, Davies D: A place for ipratropium bromide in the treatment of severe acute asthma. Br J Dis Chest 79:394-398 (1985).
10. Bryant DH: Nebulized ipratropium bromide in the treatment of acute asthma. Chest 88:24-29 (1985).
11. Leary BC, Gomm SA, Allen SC: Comparison of nebulized salbutamol with nebulized ipratropium bromide in acute asthma. Br J Dis Chest 77:159-163 (1983).
12. Ward MJ, Fentem PH, Roderick Smith WH, Davies D: Ipratropium bromide in acute asthma. Br Med J 282:598-600 (1981).
13. Watanabe S, Turner WG, Renzetti AD, Harless KW, Bigler AH, Cutillo A: Bronchodilator effects of nebulized fenoterol. Chest 80:292-299 (1981).
14. Ruffin RE, Montgomery JM, Newhouse MT: Aerosol fenoterol by intermittent positive pressure breathing in asthmatic patients. Clin Pharmacol Ther 25:821-825 (1979).
15. Strauss L, Hejal R, Galan G, Dixon L, McFadden ER Jr: Observations on the effects of aerosolized albuterol in acute asthma. Am J Respir Crit Care Med 155: 454-458 (1997).
16. 2-adrenergic bronchodilators in obstructive airway disease. Respir Care 38:1364-1388 (1993).